Here’s what you should know.
1. The probe is designed to provide superior images of living tissue within the GI tract and other structures.
2. Mr. Muldoon believes the probe could be a “major development” in the prevention and treatment of colon cancer.
3. He said it could also improve the fundamental understanding of the connection between abnormal cell progression and delivery of blood and oxygen in colon tumors.
4. The scope creates unique tissue maps that can help physicians quantify hemoglobin concentrations as well as detect any abnormal blood vessels.
5. Mr. Muldoon’s team will test the probe on mice models with colorectal adenocarcinoma, and will then test the device in a therapeutic context in the coming months.
More articles on gastroenterology:
Top 10 patient safety concerns for 2018 — diagnostic errors are No. 1
5 things to know about orthopedic surgeon Dr. Shawn Granger
Vanderbilt offers $4.8M for property to build ASC, pediatric clinic — 6 notes
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.